Symeres Weert receives new GMP certificate

Posted on 14 September 2023

This week, our facility in Weert NL received a new certificate of GMP compliance of a manufacturer from the Dutch authorities. Besides drug-substance development and manufacturing at 50–1000 L scale, we also support our clients with world-class Solid-State R&D services with high-throughput experimentation technology. We also develop and manufacture lipid ingredients for lipid nanoparticle formulations (LNPs). Formulation R&D and drug-product manufacturing is offered at our Exemplify facilities in Princeton, NJ, in the USA. All of this is in full compliance with and under the rigorous control of our QA department! Please contact our experts if you need assistance in your drug-development project.

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us